iCo Therapeutics is an emerging Vancouver-based biotechnology company committed to developing drugs for a range of human medical conditions within isolated biological environments, such as the eye, spinal cord or joints.
BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases.
Astex Technology is the leading fragment-based drug-discovery company, designing and developing new pharmaceuticals for unmet medical needs in a range of disease areas, including cancer, inflammation and Alzheimer’s disease.
Our activities include technology assessments, market analysis, and market research. We specialise in the strategic impact of new technologies on human diagnostics and therapeutics.
Protox Therapeutics is a product-focused development-stage company and a leader in advancing novel, targeted protein toxin therapeutics for the treatment of cancer and other proliferative diseases. Through the company’s INxin™ and PORxin™ technology platf
Viron Therapeutics Inc. is an emerging biotechnology company developing novel anti-inflammatory therapeutics. Viron was founded in 1997 as a spin-off of The John P. Robarts...
Immune Resolve Tolerx is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies to treat patients with immunological diseases.
Our R&D laboratory in Burlingame, CA (Y's Therapeutics, Inc.), is just south of San Francisco and San Francisco International Airport, conveniently located in the center of the San Francisco Bay Area's biotech hub.
BioMarket is an aggregator of global business intelligence in the biotech and life science industry. Companies turn to BioMarket for in-depth industry research, global business information and independent equity analysis.
Velcura Therapeutics' primary focus is to develop therapies that stimulate bone formation. We identify and validate cellular targets involved in bone formation and bone disease.
Antitope is pioneering a new generation of immunogenicity testing and protein engineering technologies. Our mission is to apply these technologies to create improved non-immunogenic biologics.
Amsterdam Molecular Therapeutics (AMT) is focused on the development of virus-based therapeutics. The lead products of AMT are an adeno-associated virus (AAV)-based gene therapy for treatment of lipoprotein lipase deficiency and a retroviral product for i
Fierce and Free: save time with FierceBiotech email newsletter Biotechnology moves fast. If it's your job to stay on top, then you need FierceBiotech, the...
AGY Therapeutics, Inc. is an emerging biopharmaceutical company dedicated to the discovery and development of new drugs and drug targets for the prevention and treatment...
LeadDiscovery was founded in 1998 by life scientists for life scientists. We support the drug discovery and development community through two key services: DailyUpdates & PharmaReports. DailyUpdates is a bulletin of breaking journal articles and drug dev
Medtech Insight, a division of Windhover Information, Inc., provides business information and intelligence on new trends, technologies, and companies in the medical device, diagnostics, and biotech marketplace. We offer a broad range of products and serv
